keyword
https://read.qxmd.com/read/38640938/pants-extension-study-how-best-to-use-anti-tnf-drugs-in-crohn-s-disease
#21
JOURNAL ARTICLE
Gareth C Parkes, Charlotte R H Hedin
No abstract text is available yet for this article.
April 16, 2024: Lancet. Gastroenterology & Hepatology
https://read.qxmd.com/read/38640937/mechanisms-and-management-of-loss-of-response-to-anti-tnf-therapy-for-patients-with-crohn-s-disease-3-year-data-from-the-prospective-multicentre-pants-cohort-study
#22
JOURNAL ARTICLE
Neil Chanchlani, Simeng Lin, Claire Bewshea, Benjamin Hamilton, Amanda Thomas, Rebecca Smith, Christopher Roberts, Maria Bishara, Rachel Nice, Charlie W Lees, Shaji Sebastian, Peter M Irving, Richard K Russell, Timothy J McDonald, James R Goodhand, Tariq Ahmad, Nicholas A Kennedy
BACKGROUND: We sought to report the effectiveness of infliximab and adalimumab over the first 3 years of treatment and to define the factors that predict anti-TNF treatment failure and the strategies that prevent or mitigate loss of response. METHODS: Personalised Anti-TNF therapy in Crohn's disease (PANTS) is a UK-wide, multicentre, prospective observational cohort study reporting the rates of effectiveness of infliximab and adalimumab in anti-TNF-naive patients with active luminal Crohn's disease aged 6 years and older...
April 16, 2024: Lancet. Gastroenterology & Hepatology
https://read.qxmd.com/read/38639899/surgical-management-of-duodenal-crohn-s-disease
#23
JOURNAL ARTICLE
Nicholas P McKenna, Katherine A Bews, Maxwell D Mirande, Franciso M Abarca Rendon, Asya Ofshteyn, Thomas Peponis, Sherief F Shawki, Scott R Kelley, Kellie L Mathis
BACKGROUND: Operative options for duodenal Crohn's disease include bypass, stricturoplasty, or resection. What factors are associated with operation selection and whether differences exist in outcomes is unknown. METHODS: Patients with duodenal Crohn's disease requiring operative intervention across a multi-state health system were identified. Patient and operative characteristics, short-term surgical outcomes, and the need for future endoscopic or surgical management of duodenal Crohn's disease were analyzed...
April 19, 2024: Langenbeck's Archives of Surgery
https://read.qxmd.com/read/38638444/evaluating-the-causal-association-between-bronchiectasis-and-different-types-of-inflammatory-bowel-disease-a-two-sample-mendelian-randomization-study
#24
JOURNAL ARTICLE
Qian Zeng, Da Hu, Yuan Li, Zhiwei Zhou, Jinfeng Wu, Xiaodong Li, Xiqiu Yu
BACKGROUND AND OBJECTIVES: Previous observational studies have established a connection between bronchiectasis and inflammatory bowel disease (IBD), but none of these studies have provided a clear explanation for the underlying cause of this relationship. The present study thus implemented Mendelian randomization (MR) design to explore possible bidirectional relationships between IBD and bronchiectasis risk, with an additional focus on Crohn's disease (CD) and ulcerative colitis (UC) as IBD subtypes...
2024: Frontiers in Immunology
https://read.qxmd.com/read/38638374/subnormal-serum-liver-enzyme-levels-a-review-of-pathophysiology-and-clinical-significance
#25
REVIEW
Elham M Youssef, George Y Wu
Subnormal levels of liver enzymes, below the lower limit of normal on local laboratory reports, can be useful diagnostically. For instance, subnormal levels of aminotransferases can be observed in vitamin B6 deficiency and chronic kidney disease. Subnormal alkaline phosphatase levels may indicate the presence of hypophosphatasia, Wilson's disease, deficiencies of divalent ions, or malnutrition. Subnormal levels of gamma glutamyl transferase may be seen in cases of acute intrahepatic cholestasis, the use of certain medications, and in bone disease...
April 28, 2024: Journal of Clinical and Translational Hepatology
https://read.qxmd.com/read/38638288/hypoxia-hypoxia-inducible-factors-and-inflammatory-bowel-diseases
#26
REVIEW
Fei Hou, Xixi Bian, Dehuai Jing, Huikuan Gao, Fengqin Zhu
Adequate oxygen supply is essential for maintaining the body's normal physiological function. In chronic inflammatory conditions such as inflammatory bowel disease (IBD), insufficient oxygen reaching the intestine triggers the regulatory system in response to environmental changes. However, the pathogenesis of IBD is still under investigation. Recent research has highlighted the significant role of hypoxia in IBD, particularly the involvement of hypoxia-inducible factors (HIF) and their regulatory mechanisms, making them promising therapeutic targets for IBD...
2024: Gastroenterology Report
https://read.qxmd.com/read/38638127/precision-medicine-in-inflammatory-bowel-disease
#27
REVIEW
Zhen Zeng, Mingshan Jiang, Xi Li, Jing Yuan, Hu Zhang
Inflammatory bowel disease (IBD) is an incurable disease characterized by remission-relapse cycles throughout its course. Both Crohn's disease (CD) and ulcerative colitis (UC), the two main forms of IBD, exhibit tendency to develop complications and substantial heterogeneity in terms of frequency and severity of relapse, thus posing great challenges to the clinical management for IBD. Current treatment strategies are effective in different ways in induction and maintenance therapies for IBD. Recent advances in studies of genetics, pharmacogenetics, proteomics and microbiome provide a strong driving force for identifying molecular markers of prognosis and treatment response, which should help clinicians manage IBD patients more effectively, and then, improve clinical outcomes and reduce treatment costs of patients...
December 2023: Precision Clinical Medicine
https://read.qxmd.com/read/38638121/causal-associations-between-autoimmune-diseases-and-sarcopenia-related-traits-a-bi-directional-mendelian-randomization-study
#28
JOURNAL ARTICLE
Chunlan Chen, Ying He
BACKGROUND: Sarcopenia is common in patients with autoimmune diseases (ADs); however, the causal associations between ADs and sarcopenia remain unclear. Therefore, this study investigated the causal associations using bi-directional Mendelian randomization analysis. METHODS: Exposure-related single-nucleotide polymorphisms (SNPs) were extracted from genome-wide association studies (GWASs). GWAS statistics for common ADs [Crohn's disease (CD), ulcerative colitis (UC), rheumatoid arthritis (RA), systemic lupus erythematosus (SLE), psoriasis (PSO), and multiple sclerosis (MS)] and sarcopenia-related traits [hand grip strength (HGS), appendicular fat-free mass (FFM), and walking pace] were obtained from public datasets...
2024: Frontiers in Genetics
https://read.qxmd.com/read/38637733/helminth-derived-proteins-as-immune-system-regulators-a-systematic-review-of-their-promise-in-alleviating-colitis
#29
JOURNAL ARTICLE
Maimonah Alghanmi, Faisal Minshawi, Tarfa A Altorki, Ayat Zawawi, Isra Alsaady, Abdallah Y Naser, Hassan Alwafi, Soa'ad M Alsulami, Ala A Azhari, Anwar M Hashem, Rowa Alhabbab
Helminth-derived proteins have immunomodulatory properties, influencing the host's immune response as an adaptive strategy for helminth survival. Helminth-derived proteins modulate the immune response by inducing anti-inflammatory cytokines, promoting regulatory T-cell development, and ultimately favouring a Th2-biased immune response. This systematic review focused on helminth-derived proteins and explored their impact on reducing inflammatory responses in mouse models of colitis. A systematic search across Medline, EMBASE, Web of Science, and Cochrane Library identified fourteen relevant studies...
April 18, 2024: BMC Immunology
https://read.qxmd.com/read/38637457/real-world-outcomes-of-patients-starting-intravenous-and-transitioning-to-subcutaneous-vedolizumab-in-inflammatory-bowel-disease
#30
JOURNAL ARTICLE
N Lamichhane, N Melas, V Bergqvist, N-P Ekholm, O Olén, J F Ludvigsson, H Hjortswang, J Marsal, C Eriksson, J Halfvarson
BACKGROUND: Real-world data on starting intravenous (IV) vedolizumab (VDZ) and transitioning to subcutaneous (SC) treatment in inflammatory bowel disease (IBD) are scarce. AIMS: To assess treatment outcomes of patients with IBD starting IV VDZ and switching to SC VDZ in routine clinical care. METHODS: Adult patients with IBD switching from IV to SC VDZ treatment between 1 March 2020 and 31 December 2021 were identified from the Swedish IBD quality register...
April 18, 2024: Digestive Diseases and Sciences
https://read.qxmd.com/read/38636151/ouch-my-pouch-a-clinician-s-guide-to-pouchitis
#31
JOURNAL ARTICLE
Vincent P Anto, Anna E Ramos, Kevin P Mollen
Pouchitis is defined as inflammation of the ileal pouch created during a restorative proctocolectomy with ileal pouch-anal anastomosis. Although the incidence of this inflammatory condition is high, the exact etiology often remains unclear and the management challenging. In this review, we summarize the clinical presentation, pathogenesis, diagnosis, and management of this common complication.
March 28, 2024: Seminars in Pediatric Surgery
https://read.qxmd.com/read/38635882/exploring-the-predictive-value-of-gut-microbiome-signatures-for-therapy-intensification-in-patients-with-inflammatory-bowel-disease-a-10-year-follow-up-study
#32
JOURNAL ARTICLE
Zainab M A Al Radi, Femke M Prins, Valerie Collij, Arnau Vich Vila, Eleonora A M Festen, Gerard Dijkstra, Rinse K Weersma, Marjolein A Y Klaassen, Ranko Gacesa
BACKGROUND: Inflammatory bowel diseases (IBDs) pose a significant challenge due to their diverse, often debilitating, and unpredictable clinical manifestations. The absence of prognostic tools to anticipate the future complications that require therapy intensification presents a substantial burden to patient private life and health. We aimed to explore whether the gut microbiome is a potential biomarker for future therapy intensification in a cohort of 90 IBD patients. METHODS: We conducted whole-genome metagenomics sequencing on fecal samples from these patients, allowing us to profile the taxonomic and functional composition of their gut microbiomes...
April 18, 2024: Inflammatory Bowel Diseases
https://read.qxmd.com/read/38635881/erratum
#33
JOURNAL ARTICLE
(no author information available yet)
No abstract text is available yet for this article.
April 18, 2024: Journal of Crohn's & Colitis
https://read.qxmd.com/read/38635299/avoidant-restrictive-food-intake-disorder-symptoms-are-not-as-frequent-as-other-eating-disorder-symptoms-when-ulcerative-colitis-is-in-remission
#34
JOURNAL ARTICLE
Helen Burton-Murray, Katheryn Kiser, Jenny Gurung, Katherine Williams, Jennifer J Thomas, Hamed Khalili
BACKGROUND AND AIM: Recent studies have shown that up to 53% of patients with inflammatory bowel disease (IBD) screen positive for avoidant/restrictive food intake disorder (ARFID). There is however concern that ARFID screening rates are over-inflated in patients with active disease. We aimed to evaluate the frequency and characteristics of ARFID symptoms using the Nine Item ARFID Screen (NIAS), and to use another eating disorder measure, the Eating Disorder Examination-Questionnaire 8 (EDE-Q8), to rule-out/characterize other eating disorder cognitive and behavioral symptoms...
April 18, 2024: Journal of Crohn's & Colitis
https://read.qxmd.com/read/38634640/co-development-of-three-dietary-indices-to-facilitate-dietary-intake-assessment-of-pediatric-crohn-s-disease-patients
#35
JOURNAL ARTICLE
Antonia Harvey, Jessica Mannette, Rotem Sigall-Boneh, Brad Macintyre, Matthew Parrott, Leah Cahill, Jessica Connors, Anthony Otley, Johan van Limbergen, Shannan Grant
Literature on dietary behaviours of the pediatric Crohn's Disease (CD) population and the relationship between dietary intake and CD activity is limited. Three dietary indices were developed and tested to conduct dietary pattern analysis in pediatric patients with CD consuming a free diet following remission induction via exclusive enteral nutrition ( n  = 11). Index scores underwent descriptive and inferential analysis. The mean adjusted scores (out of 100) for the Pediatric Western Diet Index, Pediatric Prudent Diet Index, and Pediatric-Adapted 2010 Alternate Healthy Eating Index (PA2010-AHEI) were 29...
April 18, 2024: Canadian Journal of Dietetic Practice and Research
https://read.qxmd.com/read/38632572/cystitis-glandularis-with-concomitant-crohn-s-disease-leading-to-a-paroxysm-of-crohn-s-disease-with-ulcerated-external-iliac-vessels
#36
JOURNAL ARTICLE
Wu Ronghua, Zheng Ji, Liu Gang, Zhang Yun, Nie Xubiao
•we report the case of a 36-year-old female patient who presented to our hospital with a diagnosis of cystitis glandularis manifesting as a vesicovaginal fistula. She underwent cystoscopic biopsy at a local hospital, but anti-inflammatory treatment was ineffective, and the patient was experiencing low urination frequency and urgency, as well as pain. The patient underwent laparoscopic repair of a cystoscopy-confirmed vesicovaginal fistula. After surgery, the patient experienced a paroxysm of Crohn's disease with multiple small bowel fistulas and erosion of the external iliac vessels that ruptured to form an external iliac vessel small bowel fistula...
April 17, 2024: BMC Urology
https://read.qxmd.com/read/38631839/defining-predictors-of-responsiveness-to-advanced-therapies-in-crohn-s-disease-and-ulcerative-colitis-protocol-for-the-ibd-response-and-nested-cd-metaresponse-prospective-multicentre-observational-cohort-study-in-precision-medicine
#37
JOURNAL ARTICLE
Nicola J Wyatt, Hannah Watson, Carl A Anderson, Nicholas A Kennedy, Tim Raine, Tariq Ahmad, Dean Allerton, Michelle Bardgett, Emma Clark, Dawn Clewes, Cristina Cotobal Martin, Mary Doona, Jennifer A Doyle, Katherine Frith, Helen C Hancock, Ailsa L Hart, Victoria Hildreth, Peter M Irving, Sameena Iqbal, Ciara Kennedy, Andrew King, Sarah Lawrence, Charlie W Lees, Robert Lees, Laura Letchford, Trevor Liddle, James O Lindsay, Rebecca H Maier, John C Mansfield, Julian R Marchesi, Naomi McGregor, Rebecca E McIntyre, Jasmin Ostermayer, Tolulope Osunnuyi, Nick Powell, Natalie J Prescott, Jack Satsangi, Shriya Sharma, Tara Shrestha, Ally Speight, Michelle Strickland, James Ms Wason, Kevin Whelan, Ruth Wood, Gregory R Young, Xinyue Zhang, Miles Parkes, Christopher J Stewart, Luke Jostins-Dean, Christopher A Lamb
INTRODUCTION: Characterised by chronic inflammation of the gastrointestinal tract, inflammatory bowel disease (IBD) symptoms including diarrhoea, abdominal pain and fatigue can significantly impact patient's quality of life. Therapeutic developments in the last 20 years have revolutionised treatment. However, clinical trials and real-world data show primary non-response rates up to 40%. A significant challenge is an inability to predict which treatment will benefit individual patients...
April 17, 2024: BMJ Open
https://read.qxmd.com/read/38631808/quality-of-reporting-inflammatory-bowel-disease-randomised-controlled-trials-a-systematic-review
#38
JOURNAL ARTICLE
Morris Gordon, Jamal Khudr, Vassiliki Sinopoulou, Svetlana Lakunina, Aditi Rane, Anthony Akobeng
OBJECTIVE: Our objective was to perform a systemic evaluation of the risk of bias in randomised controlled trial (RCT) reports published on inflammatory bowel disease (IBD). DESIGN: We assessed the risk of bias using the Cochrane tool, as indicators of poor methodology or subsequently poor reporting. We systematically selected, with dual independent judgements, all studies published on IBD with no time limits and assessed the methodological quality of included studies again using independent dual ratings...
April 17, 2024: BMJ Open Gastroenterology
https://read.qxmd.com/read/38630199/population-pharmacokinetics-of-adalimumab-in-juvenile-idiopathic-arthritis-patients-a-retrospective-cohort-study-using-clinical-care-data
#39
JOURNAL ARTICLE
Amara Nassar-Sheikh Rashid, Femke Hooijberg, Sandy C Bergkamp, Mariken P Gruppen, Taco W Kuijpers, Mike Nurmohamed, Theo Rispens, Gertjan Wolbink, J Merlijn van den Berg, Dieneke Schonenberg-Meinema, Ron A A Mathôt
BACKGROUND AND OBJECTIVE: Juvenile idiopathic arthritis (JIA) is a chronic autoimmune disorder that primarily affects the joints in children. Notably, it is known to co-occur with uveitis. Adalimumab, a monoclonal anti-TNF antibody, is effective in treating both conditions. A deeper understanding of the pharmacokinetics (PK) of adalimumab in JIA is crucial to advance in more personalized treatment approaches. The objective of this study is to evaluate the population PK profile of adalimumab in JIA and to explain causes for its variability...
April 17, 2024: Paediatric Drugs
https://read.qxmd.com/read/38629651/factors-associated-with-surgical-resection-in-patients-with-crohn-s-disease-long-term-evaluation
#40
JOURNAL ARTICLE
Sandro da Costa Ferreira, Lílian Rose Otoboni Aprile, Rogério Serafim Parra, Marley Ribeiro Feitosa, Patrícia Picardi Morais de Castro, Gleici de Castro da Silva Perdoná, Omar Feres, José Joaquim Ribeiro da Rocha, Luiz Ernesto de Almeida Troncon
PURPOSE: To evaluate patient characteristics and factors associated with surgical resection in patients with Crohn's disease (CD). METHODS: An analysis was performed on data from 295 patients with CD in follow-up from 2001 to 2018. Medical record data comprised age, gender, location, behavior and duration of the CD, smoking, and extraintestinal manifestation. Patients were divided into two groups according to the presence or absence of surgical resection. RESULTS: Out of the 295 patients with CD, 155 underwent surgical resection (53...
2024: Acta Cirúrgica Brasileira
keyword
keyword
25821
2
3
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.